Sixpex Aromapex is exemestane in tablet form, packaged as a sachet holding 30 tablets at 25 mg each. The substance is an aromatase inhibitor sold under its generic name, positioned alongside anastrozole in the anti-estrogen category but distinguished by its steroidal structure where anastrozole is non-steroidal. Sixpex is based in the USA and has been producing this line since 2024.

Exemestane 25 mg Tablet Strength and Count

Each tablet carries 25 mg of exemestane, the standard concentration for this compound across most labs. The sachet holds 30 tablets total, giving a higher count than many blister packs in the same category, which often contain 10 or 20 tablets. The sachet format differs from the rigid blister presentation used by labs such as Beligas or Xeno, offering flexibility in storage while maintaining the same per-tablet dosage. Where some exemestane listings show 50-tablet bottles, this sachet sits in the middle range by count.

Aromapex Beside Other Exemestane and Anastrozole Options

Aromapex competes directly with other 25 mg exemestane tablets but is listed in the broader anti-estrogen category alongside anastrozole products, typically dosed at 1 mg. The two substances differ in classification—exemestane is a Type I inhibitor, anastrozole a Type II—so comparing them by label alone requires recognizing that their dosages are not equivalent. Among exemestane listings, Aromapex matches the prevailing strength but offers a sachet rather than blister or bottle, and its 30-tablet count falls between the smaller 10-tablet packs and the larger 50-count bottles from other manufacturers.